---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-035256"
form_type: "8-K"
ticker: "IPSC"
cik: "0001850119"
company_name: "Century Therapeutics, Inc."
filed_at: "2026-03-26T23:59:59+00:00"
generated_at: "2026-05-15T08:53:19.219851+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Century Therapeutics updates ATM program; $131.6M remaining under $150M facility

## Summary
- New prospectus supplement filed March 26, 2026 for existing ATM program under effective shelf.
- Up to $150M in common stock may be sold via ATM; $18.38M already sold.
- $131.62M remains available for future issuance through TD Securities as agent.
- Goodwin Procter LLP opinion on share validity included as Exhibit 5.1.

## SEC filing metadata
- accession: 0001104659-26-035256
- form_type: 8-K
- ticker: IPSC
- cik: 0001850119
- company_name: Century Therapeutics, Inc.
- filed_at: 2026-03-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850119/000110465926035256/0001104659-26-035256-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850119/000110465926035256/tm269823d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-035256
- JSON: https://secwatch.observer/filing/0001104659-26-035256.json
- Plain text: https://secwatch.observer/filing/0001104659-26-035256.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.